Purinergic Receptors in Ocular Ciliary Epithelial Cells

Martin Wax, Darshak M. Sanghavi, Catherine H. Lee, Milan Kapadia

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Adenosine and ATP have been shown to activate separate cell surface purinergic receptors which have been designated P1 for adenosine and P2 for ATP. The pharmacological characterization of P1 and P2 purinergic receptor-mediated signal transduction has been performed in cultured cell lines of the ciliary epithelium. In ODM Clone-2, a cell line derived from human nonpigmented ciliary epithelium (NPE) and in a clone derived from bovine pigmented ciliary epithelium (PE), we observed that adenosine inhibits adenylate cyclase activity at high potency (nM) and stimulates adenylate cyclase activity at low potency (μM) suggesting the presence of P1 subtypes on these cell membranes. The selective agonist cyclopentyladenosine (CPA) was effective at inhibiting forskolin-stimulated adenylate cyclase in these cells. The IC50 for CPA in both NPE and PE was approximately 1 nM in the absence, and 11 nM in the presence of 3-isobutyl-1-methylxanthine (IBMX). In NPE, the selective agonist 2-[p-(2-carboxyethyl)phenethylamino]-5′-N-ethylcarboxamido adenosine (CGS 21680) stimulated adenylyl cyclase with an EC50 of 11 ± 4 nM in the presence of 4-(3-butoxy-4-methyoxybenzyl)-2-imidazolidinone (RO-20-1724), a phosphodiesterase inhibitor devoid of adenosine receptor antagonism, and 61 ± 8 μM in the presence of IBMX. In PE cells, EC50 value of RO-20-1724 was 19 ± 5 nM (n = 3). The characterization of P2 receptors based upon the ability of ATP and its related analogues to stimulate inositol phosphate production reveal the presence of a putative P2U, receptor in both cell types.

Original languageEnglish (US)
Pages (from-to)89-95
Number of pages7
JournalExperimental Eye Research
Volume57
Issue number1
DOIs
StatePublished - Jul 1993

Fingerprint

Purinergic Receptors
Epithelium
Epithelial Cells
Adenylyl Cyclases
Adenosine
Adenosine Triphosphate
Clone Cells
Purinergic P2Y2 Receptors
1-Methyl-3-isobutylxanthine
Cell Line
Purinergic P1 Receptors
Inositol Phosphates
Phosphodiesterase Inhibitors
Cell Surface Receptors
Colforsin
Inhibitory Concentration 50
Cultured Cells
Signal Transduction
Cell Membrane
Pharmacology

Keywords

  • adenylyl cyclase
  • ATP
  • ciliary epithelia
  • phosphoinositide hydrolysis
  • purinergic receptors
  • UTP

ASJC Scopus subject areas

  • Sensory Systems
  • Ophthalmology

Cite this

Purinergic Receptors in Ocular Ciliary Epithelial Cells. / Wax, Martin; Sanghavi, Darshak M.; Lee, Catherine H.; Kapadia, Milan.

In: Experimental Eye Research, Vol. 57, No. 1, 07.1993, p. 89-95.

Research output: Contribution to journalArticle

Wax, M, Sanghavi, DM, Lee, CH & Kapadia, M 1993, 'Purinergic Receptors in Ocular Ciliary Epithelial Cells', Experimental Eye Research, vol. 57, no. 1, pp. 89-95. https://doi.org/10.1006/exer.1993.1102
Wax, Martin ; Sanghavi, Darshak M. ; Lee, Catherine H. ; Kapadia, Milan. / Purinergic Receptors in Ocular Ciliary Epithelial Cells. In: Experimental Eye Research. 1993 ; Vol. 57, No. 1. pp. 89-95.
@article{7842e6a705004325ba15f925323e6b9f,
title = "Purinergic Receptors in Ocular Ciliary Epithelial Cells",
abstract = "Adenosine and ATP have been shown to activate separate cell surface purinergic receptors which have been designated P1 for adenosine and P2 for ATP. The pharmacological characterization of P1 and P2 purinergic receptor-mediated signal transduction has been performed in cultured cell lines of the ciliary epithelium. In ODM Clone-2, a cell line derived from human nonpigmented ciliary epithelium (NPE) and in a clone derived from bovine pigmented ciliary epithelium (PE), we observed that adenosine inhibits adenylate cyclase activity at high potency (nM) and stimulates adenylate cyclase activity at low potency (μM) suggesting the presence of P1 subtypes on these cell membranes. The selective agonist cyclopentyladenosine (CPA) was effective at inhibiting forskolin-stimulated adenylate cyclase in these cells. The IC50 for CPA in both NPE and PE was approximately 1 nM in the absence, and 11 nM in the presence of 3-isobutyl-1-methylxanthine (IBMX). In NPE, the selective agonist 2-[p-(2-carboxyethyl)phenethylamino]-5′-N-ethylcarboxamido adenosine (CGS 21680) stimulated adenylyl cyclase with an EC50 of 11 ± 4 nM in the presence of 4-(3-butoxy-4-methyoxybenzyl)-2-imidazolidinone (RO-20-1724), a phosphodiesterase inhibitor devoid of adenosine receptor antagonism, and 61 ± 8 μM in the presence of IBMX. In PE cells, EC50 value of RO-20-1724 was 19 ± 5 nM (n = 3). The characterization of P2 receptors based upon the ability of ATP and its related analogues to stimulate inositol phosphate production reveal the presence of a putative P2U, receptor in both cell types.",
keywords = "adenylyl cyclase, ATP, ciliary epithelia, phosphoinositide hydrolysis, purinergic receptors, UTP",
author = "Martin Wax and Sanghavi, {Darshak M.} and Lee, {Catherine H.} and Milan Kapadia",
year = "1993",
month = "7",
doi = "10.1006/exer.1993.1102",
language = "English (US)",
volume = "57",
pages = "89--95",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Purinergic Receptors in Ocular Ciliary Epithelial Cells

AU - Wax, Martin

AU - Sanghavi, Darshak M.

AU - Lee, Catherine H.

AU - Kapadia, Milan

PY - 1993/7

Y1 - 1993/7

N2 - Adenosine and ATP have been shown to activate separate cell surface purinergic receptors which have been designated P1 for adenosine and P2 for ATP. The pharmacological characterization of P1 and P2 purinergic receptor-mediated signal transduction has been performed in cultured cell lines of the ciliary epithelium. In ODM Clone-2, a cell line derived from human nonpigmented ciliary epithelium (NPE) and in a clone derived from bovine pigmented ciliary epithelium (PE), we observed that adenosine inhibits adenylate cyclase activity at high potency (nM) and stimulates adenylate cyclase activity at low potency (μM) suggesting the presence of P1 subtypes on these cell membranes. The selective agonist cyclopentyladenosine (CPA) was effective at inhibiting forskolin-stimulated adenylate cyclase in these cells. The IC50 for CPA in both NPE and PE was approximately 1 nM in the absence, and 11 nM in the presence of 3-isobutyl-1-methylxanthine (IBMX). In NPE, the selective agonist 2-[p-(2-carboxyethyl)phenethylamino]-5′-N-ethylcarboxamido adenosine (CGS 21680) stimulated adenylyl cyclase with an EC50 of 11 ± 4 nM in the presence of 4-(3-butoxy-4-methyoxybenzyl)-2-imidazolidinone (RO-20-1724), a phosphodiesterase inhibitor devoid of adenosine receptor antagonism, and 61 ± 8 μM in the presence of IBMX. In PE cells, EC50 value of RO-20-1724 was 19 ± 5 nM (n = 3). The characterization of P2 receptors based upon the ability of ATP and its related analogues to stimulate inositol phosphate production reveal the presence of a putative P2U, receptor in both cell types.

AB - Adenosine and ATP have been shown to activate separate cell surface purinergic receptors which have been designated P1 for adenosine and P2 for ATP. The pharmacological characterization of P1 and P2 purinergic receptor-mediated signal transduction has been performed in cultured cell lines of the ciliary epithelium. In ODM Clone-2, a cell line derived from human nonpigmented ciliary epithelium (NPE) and in a clone derived from bovine pigmented ciliary epithelium (PE), we observed that adenosine inhibits adenylate cyclase activity at high potency (nM) and stimulates adenylate cyclase activity at low potency (μM) suggesting the presence of P1 subtypes on these cell membranes. The selective agonist cyclopentyladenosine (CPA) was effective at inhibiting forskolin-stimulated adenylate cyclase in these cells. The IC50 for CPA in both NPE and PE was approximately 1 nM in the absence, and 11 nM in the presence of 3-isobutyl-1-methylxanthine (IBMX). In NPE, the selective agonist 2-[p-(2-carboxyethyl)phenethylamino]-5′-N-ethylcarboxamido adenosine (CGS 21680) stimulated adenylyl cyclase with an EC50 of 11 ± 4 nM in the presence of 4-(3-butoxy-4-methyoxybenzyl)-2-imidazolidinone (RO-20-1724), a phosphodiesterase inhibitor devoid of adenosine receptor antagonism, and 61 ± 8 μM in the presence of IBMX. In PE cells, EC50 value of RO-20-1724 was 19 ± 5 nM (n = 3). The characterization of P2 receptors based upon the ability of ATP and its related analogues to stimulate inositol phosphate production reveal the presence of a putative P2U, receptor in both cell types.

KW - adenylyl cyclase

KW - ATP

KW - ciliary epithelia

KW - phosphoinositide hydrolysis

KW - purinergic receptors

KW - UTP

UR - http://www.scopus.com/inward/record.url?scp=0027326528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027326528&partnerID=8YFLogxK

U2 - 10.1006/exer.1993.1102

DO - 10.1006/exer.1993.1102

M3 - Article

C2 - 8405176

AN - SCOPUS:0027326528

VL - 57

SP - 89

EP - 95

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

IS - 1

ER -